Lumos Diagnostics Holdings Limited
LDXHF
$0.015
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.15M | 3.15M | 4.18M | 4.18M | 1.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.15M | 3.15M | 4.18M | 4.18M | 1.38M |
| Cost of Revenue | 1.03M | 1.03M | 1.62M | 1.62M | 621.50K |
| Gross Profit | 2.12M | 2.12M | 2.56M | 2.56M | 761.50K |
| SG&A Expenses | 3.15M | 3.15M | 2.90M | 2.90M | 2.90M |
| Depreciation & Amortization | 672.00K | 672.00K | 700.50K | 700.50K | 647.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.89M | 4.89M | 5.20M | 5.20M | 4.20M |
| Operating Income | -1.73M | -1.73M | -1.01M | -1.01M | -2.82M |
| Income Before Tax | -1.40M | -1.40M | -1.09M | -1.09M | -3.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.40M | -1.40M | -1.09M | -1.09M | -3.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.40M | -1.40M | -1.09M | -1.09M | -3.21M |
| EBIT | -1.73M | -1.73M | -1.01M | -1.01M | -2.82M |
| EBITDA | -1.06M | -1.06M | -842.30K | -691.30K | -2.17M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 612.96M | 612.96M | 481.94M | 481.94M | 444.45M |
| Average Diluted Shares Outstanding | 612.96M | 612.96M | 481.94M | 481.94M | 444.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
